Risks and benefits of phase 1 oncology trials, revisited

被引：65
|
作者：
Kurzrock, R
Benjamin, RS
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Div Canc Med, Phase 1 Program, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Div Canc Med, Dept Sarcoma Med Oncol, Houston, TX 77030 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 352卷 / 09期
关键词：
D O I：
10.1056/NEJMe058007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：930 / 932
页数：3
相关论文
共 50 条
  • [31] Participants in Phase 1 Oncology Research Trials Are Vulnerable
    Berghmans, Ron
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (20) : 2287 - 2288
  • [32] Examining the Effect of Teleconferences on Oncology Phase 1 Trials
    Mckane, Alexandra
    Sima, Chao
    Fleck, Sharon
    Weiss, Glen J.
    JOURNAL OF CANCER, 2013, 4 (06): : 464 - 467
  • [33] Comment regarding benefit in phase 1 oncology trials
    Morse, Michael
    CLINICAL TRIALS, 2008, 5 (06) : 626 - 626
  • [34] Changing trends in phase 1 oncology clinical trials
    Kelly, Richard
    Guo, Christina
    Desai, Jayesh
    Tran, Ben
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2024, 37
  • [35] RISKS OF NON-ONCOLOGY PHASE I RESEARCH Time to abandon three-phase trials?
    Metcalfe, Andrew V.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 352
  • [36] Risks (and Benefits) in Comparative Effectiveness Research Trials
    Feudtner, Chris
    Schreiner, Mark
    Lantos, John D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (10): : 892 - 894
  • [37] Phase III trials in oncology
    Imadalou, K
    Cvitkovic, E
    BULLETIN DU CANCER, 1999, 86 (02) : 143 - 147
  • [38] GENE-THERAPY IN ONCOLOGY - OUTLOOK, BENEFITS AND RISKS
    KIEHNTOPF, M
    BRACH, MA
    HERNNANN, F
    ONKOLOGIE, 1995, 18 : 16 - 26
  • [39] Website information on oncology drug benefits vs risks
    Reactions Weekly, 2016, 1620 (1) : 11 - 11
  • [40] PHASE 1 ONCOLOGY TRIALS: COMING TOGETHER TO MEET THE CHALLENGES
    Delengowski, Anne
    Newhall, Tracey
    ONCOLOGY NURSING FORUM, 2023, 50 (02)
12345